Bronchopulmonale Dysplasie (BPD)

Translated title of the contribution: Bronchopulmonary dysplasia (BPD)

E. Herting*

*Corresponding author for this work


Old vs. new BPD: Bronchopulmonary dysplasia (BPD) was described about 50 years ago as a fibroproliferative chronic lung disease in consequence of mechanical ventilation/oxygen exposure in premature infants with respiratory distress syndrome (old BPD). Surfactant therapy with increased survival of extremely premature infants identified a new type of an immaturity-related multisystem disorder that is characterized by a stop/simplification of alveolarisation and lung capillary development (new BPD). Therapy: To date, mainly symptomatic treatment exists. However, growth factors and stem cell therapy have recently been tested with some success in animal experiments. Outcome: Survivors of new BPD may have problems in adult life concerning lung and cardiovascular function, growth and neurosensory and/or motor development.

Translated title of the contributionBronchopulmonary dysplasia (BPD)
Original languageGerman
JournalMonatsschrift fur Kinderheilkunde
Issue number5
Pages (from-to)417-424
Number of pages8
Publication statusPublished - 05.2013

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)


Dive into the research topics of 'Bronchopulmonary dysplasia (BPD)'. Together they form a unique fingerprint.

Cite this